These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36924097)

  • 1. Antimicrobial Peptides: A Promising Strategy for Anti-tuberculosis Therapeutics.
    Ning Y; Wang L; Wang M; Meng X; Qiao J
    Protein Pept Lett; 2023; 30(4):280-294. PubMed ID: 36924097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial Peptides as Immunomodulators and Antimycobacterial Agents to Combat Mycobacterium tuberculosis: a Critical Review.
    R PA; Anbarasu A
    Probiotics Antimicrob Proteins; 2023 Dec; 15(6):1539-1566. PubMed ID: 36576687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial peptides as an alternative to anti-tuberculosis drugs.
    AlMatar M; Makky EA; Yakıcı G; Var I; Kayar B; Köksal F
    Pharmacol Res; 2018 Feb; 128():288-305. PubMed ID: 29079429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between antimicrobial peptides and mycobacteria.
    Gutsmann T
    Biochim Biophys Acta; 2016 May; 1858(5):1034-43. PubMed ID: 26851776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taming the Devil: Antimicrobial Peptides for Safer TB Therapeutics.
    Jadhav K; Singh R; Ray E; Singh AK; Verma RK
    Curr Protein Pept Sci; 2022; 23(10):643-656. PubMed ID: 35619262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial peptides and proteins in mycobacterial therapy: current status and future prospects.
    Padhi A; Sengupta M; Sengupta S; Roehm KH; Sonawane A
    Tuberculosis (Edinb); 2014 Jul; 94(4):363-73. PubMed ID: 24813349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-mycobacterial peptides: from human to phage.
    Teng T; Liu J; Wei H
    Cell Physiol Biochem; 2015; 35(2):452-66. PubMed ID: 25613372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial peptides as novel anti-tuberculosis therapeutics.
    Silva JP; Appelberg R; Gama FM
    Biotechnol Adv; 2016; 34(5):924-940. PubMed ID: 27235189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural antimicrobial peptides against Mycobacterium tuberculosis.
    Abedinzadeh M; Gaeini M; Sardari S
    J Antimicrob Chemother; 2015 May; 70(5):1285-9. PubMed ID: 25681127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic amphipathic D-enantiomeric antimicrobial peptides with in vitro and ex vivo activity against drug-resistant Mycobacterium tuberculosis.
    Lan Y; Lam JT; Siu GK; Yam WC; Mason AJ; Lam JK
    Tuberculosis (Edinb); 2014 Dec; 94(6):678-89. PubMed ID: 25154927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review on anti-tuberculosis peptides: Impact of peptide structure on anti-tuberculosis activity.
    Yathursan S; Wiles S; Read H; Sarojini V
    J Pept Sci; 2019 Nov; 25(11):e3213. PubMed ID: 31515916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachyplesin and CyLoP-1 as efficient anti-mycobacterial peptides: A novel finding.
    Priya A; Aditya A; Budagavi DP; Chugh A
    Biochim Biophys Acta Biomembr; 2022 Jul; 1864(7):183895. PubMed ID: 35271828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-active and DNA binding related double-action antimycobacterial mechanism of antimicrobial peptide W3R6 and its synthetic analogs.
    Wang X; Feng L; Li M; Dong W; Luo X; Shang D
    Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130415. PubMed ID: 37336295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of antimicrobial peptides as next-generation therapeutics in the biomedical world.
    Datta M; Rajeev A; Chattopadhyay I
    Biotechnol Genet Eng Rev; 2024 Nov; 40(3):2458-2496. PubMed ID: 37036043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial peptides grafted onto the surface of N-acetylcysteine-chitosan nanoparticles can revitalize drugs against clinical isolates of Mycobacterium tuberculosis.
    Primo LMDG; Roque-Borda CA; Carnero Canales CS; Caruso IP; de Lourenço IO; Colturato VMM; Sábio RM; de Melo FA; Vicente EF; Chorilli M; da Silva Barud H; Barbugli PA; Franzyk H; Hansen PR; Pavan FR
    Carbohydr Polym; 2024 Jan; 323():121449. PubMed ID: 37940311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
    Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
    Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.